Search results
Results from the WOW.Com Content Network
The name "Life Technologies" was an old name from the history of Invitrogen. GIBCO (Grand Island Biological Company) had been founded around 1960 in New York; in 1983 GIBCO merged with a reagent company called Bethesda Research Laboratories (BRL) and the merged company was named Life Technologies. In 2000, Invitrogen acquired Life Technologies ...
The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. [30] In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs manufactures, and delivers technologies used in bioprocessing. [31]
That year the company was the world's leading manufacturer of instruments and reagents for polymerase chain reaction (PCR). It marketed PCR reagents kits in alliance with Hoffman-La Roche Inc. [3] In 1994, Perkin-Elmer reported net revenues of over $1 billion, of which Life Sciences accounted for 42% of the business. The company has 5,954 ...
The world's second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ...
Life Technologies , a giant in the gene sequencing space, had a healthy start to 2013. This stock popped in January on speculation that the company was exploring the possibility of a buyout.
Invitrogen was founded in 1987 by Lyle Turner, Joe Fernandez, and William McConnell and was incorporated in 1989. The company initially found success with its kits for molecular cloning—notably, The Librarian, a kit for making cDNA libraries, and the FastTrack Kit for mRNA isolation from biological samples.
The following is a list of publicly traded companies having the greatest market capitalization, sometimes described as their "market value": [1]. Market capitalization is calculated by multiplying the share price on a selected day and the number of outstanding shares on that day.
Shiller states that this plot "confirms that long-term investors—investors who commit their money to an investment for ten full years—did do well when prices were low relative to earnings at the beginning of the ten years. Long-term investors would be well advised, individually, to lower their exposure to the stock market when it is high ...